![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences to Present DB959 At the 'Annual Targeting Diabetes with Novel Therapeutics' Meeting Sponsored by Cambridge Healthtech Institute
May 14, 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., May 14, 2009 (GLOBE NEWSWIRE) -- Today DARA BioSciences, Inc. (Nasdaq:DARA) announced that the DB959 program has been identified by Cambridge Healthtech Institute ("CHI") for inclusion...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Announces Positive Trial Results of KRN5500 for Treatment of Neuropathic Pain in Patients With Cancer
May 12, 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., May 12, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) today announced positive results from a Phase 2a clinical trial of KRN5500 for treatment of neuropathic pain in...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Appoints Gail F. Lieberman to Its Board of Directors
April 30, 2009 13:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., April 30, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced the appointment of Gail F. Lieberman to its Board of Directors. The appointment was effective April 27,...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences, Inc. Announces Going Concern and NASDAQ Notice
April 10, 2009 17:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., April 10, 2009 (GLOBE NEWSWIRE) -- DARA Biosciences, Inc. (Nasdaq:DARA) ("DARA" or the "Company"), a development-stage pharmaceutical company, announced today that the audit report...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences to Present Abstracts for DB959 At American Diabetes Association Scientific Sessions
March 30, 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., March 30, 2009 (GLOBE NEWSWIRE) -- Today DARA BioSciences, Inc. (Nasdaq:DARA) announced that two abstracts have been accepted for presentation at the annual American Diabetes...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
United States Food and Drug Administration ('FDA') Approves DARA Investigational New Drug Application ('IND') for DB959 -- An Oral Medication Intended for the Treatment of Type 2 Diabetes
March 10, 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., March 10, 2009 (GLOBE NEWSWIRE) -- DARA Biosciences, Inc. (Nasdaq:DARA), today announced that the United States Food and Drug Administration ("FDA") has cleared the Company's...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA Raises $1,000,000 in New Capital
February 05, 2009 07:45 ET
|
DARA BioSciences, Inc.
Richard A. Franco, Sr. Appointed as Chief Executive Officer and Director
DARA Files Investigational New Drug Application ("IND") With the United
States Food and Drug Administration...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Raises $2,255,000 Through the Sale of Common Stock and Warrants
October 21, 2008 17:58 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Oct. 21, 2008 (GLOBE NEWSWIRE) -- DARA Biosciences, Inc. (Nasdaq:DARA), a development-stage pharmaceutical company focused on compounds designed to address diabetes, neuropathic pain...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Announces Completion of Toxicology Studies for Its PPAR-delta/gamma Agonist, DB959
October 02, 2008 09:18 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Oct. 2, 2008 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), a development-stage pharmaceutical company, announced the completion of all toxicology studies necessary for...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Plans to Restate Financial Statements for the Quarter Ended March 31, 2008 to Reflect Increased Valuation of Investment
August 14, 2008 18:22 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Aug. 14, 2008 (PRIME NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) reported today that it expects to restate its financial statements for the quarter ended March 31, 2008, to...